Man Group
ZYME icon

Man Group’s Zymeworks ZYME Stock Holding History

Man Group’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.51M Buy
210,779
+20,889
+11% +$531K 0.01% 1085
2026
Q1 		$4.75M Buy
189,890
+114,572
+152% +$2.71M 0.01% 1194
2025
Q4 		$1.98M Sell
75,318
-83,298
-53% -$1.82M ﹤0.01% 1453
2025
Q3 		$2.71M Buy
158,616
+123,210
+348% +$1.76M ﹤0.01% 1297
2025
Q2 		$444K Buy
35,406
+24,547
+226% +$292K ﹤0.01% 1870
2025
Q1 		$129K Buy
+10,859
New +$148K ﹤0.01% 2094
2024
Q2 		– Sell
-39,583
Closed -$416K – 2314
2024
Q1 		$416K Sell
39,583
-3,186
-7% -$35.4K ﹤0.01% 1846
2023
Q4 		$444K Buy
+42,769
New +$341K ﹤0.01% 1716
2023
Q3 		– Sell
-22,514
Closed -$166K – 1788
2023
Q2 		$195K Buy
+22,514
New +$202K ﹤0.01% 1824
2023
Q1 		– Sell
-18,289
Closed -$159K – 1953
2022
Q4 		$144K Sell
18,289
-142,256
-89% -$1,000K ﹤0.01% 1836
2022
Q3 		$987K Buy
+160,545
New +$968K ﹤0.01% 1292
2022
Q2 		– Sell
-64,400
Closed -$389K – 1578
2022
Q1 		$422K Buy
+64,400
New +$574K ﹤0.01% 1641
2020
Q3 		– Sell
-11,837
Closed -$427K – 1898
2020
Q2 		$427K Buy
+11,837
New +$436K ﹤0.01% 1489
2020
Q1 		– Sell
-44,294
Closed -$2.01M – 1933
2019
Q4 		$2.01M Buy
+44,294
New +$1.61M 0.01% 1329

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Man Group's ZYME Position: Q2 2026 in Review

Man Group increased its Zymeworks (ZYME) stake by 11% in Q2 2026, buying an estimated $531K and bringing the position to 210,779 shares worth $5.51M. The position accounts for 0.01% of the portfolio, ranked #1085.

Man Group first reported a position in ZYME in Q4 2019 and has held it in 14 quarters since. 203 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Man Group held 210,779 shares of Zymeworks worth $5.51M as of Q2 2026.
  • Man Group bought 20,889 Zymeworks shares in Q2 2026, an estimated $531K.
  • Zymeworks made up 0.01% of Man Group's portfolio in Q2 2026, its #1085 holding.
  • Man Group first reported a position in Zymeworks in Q4 2019 and has held it in 14 quarters since.
  • 203 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.